ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-proliferation and anti-migration effects of Yishen Tongbi decoction in experimental rheumatoid arthritis by suppressing SLC3A2/integrin β3 signaling pathways

Jiao, Wei; Xu, Jia; Wu, Danbin; Yu, Jiahui; Zhang, Mingying; Liu, Lijuan; Chen, Guangxing*广州中医药大学; 1
PHYTOMEDICINE2023-6DOI: 10.1016/j.phymed.2023.154741
1被引21阅读
引用收藏
分享

摘要

Background: Yishen Tongbi (YSTB) decoction is a patented herbal formula that is used in China to treat rheumatoid arthritis (RA); however, the exact mechanism of its anti-synovial hyperplasia efficacy has not been fully elucidated. @@@ Purpose: Based on our previous proteomics study, we aimed to reveal whether YSTB inhibits the proliferation and migration of RA-FLSs through the SLC3A2/integrin beta 3 pathway in vivo and in vitro. @@@ Study design: The study design consists of three parts, a comparison of the expression of SLC3A2 and integrin beta 3 in synovial tissues of RA and OA patients; an animal experiment to verify the pharmacodynamic effect of YSTB, and in vitro experiment to elucidate the specific mechanism of YSTB. @@@ Methods: The expression of SLC3A2 and integrin beta 3 in the synovial tissues of patients with RA and osteoarthritis (OA) patients were detected by immunohistochemistry (IHC). In vitro, firstly, the proliferation and migration abilities of HFLS (human fibroblast-like synoviocytes) and HFLS-RA (human fibroblast-like synoviocytes-RA) cells were compared by EdU staining and wound healing assays, respectively, and the differences in the expression and localization of SLC3A2, integrin beta 3, p-FAK and p-Src between HFLS and HFLS-RA cells were detected by IF and WB. In vivo, DBA/1 mice were injected with bovine collagen II to construct a CIA mouse model. Paw swelling, body weight and the arthritis index (AI) were used as basic treatment evaluation indicators for YSTB. Micro-CT and histopathological analyses of the knee and ankle joints were also performed. In addition, the expression of SLC3A2, integrin beta 3, p-FAK and p-Src in the synovial tissue of mice was detected by IHC. Subsequently, CCK-8 was used to screen for suitable concentrations of YSTB for use in HFLS-RA cells. EdU staining and transwell migration assays were performed to evaluate the inhibitory effect of YSTB on cell proliferation and migration, and WB was conducted to assess whether YSTB inhibited HFLS-RA migration through downregulation of the SLC3A2/integrin beta 3 pathways. @@@ Results: IHC showed that the expression of SLC3A2 and integrin beta 3 was higher in RA synovial tissues than in OA tissues. In vivo experiments showed that YSTB inhibited synovial hyperplasia, prevented bone destruction, and reduced the expression of SLC3A2, integrin beta 3, p-FAK and p-Src. In vitro experiments showed that YSTB inhibited HFLS-RA migration and proliferation by inhibiting the expression of SLC3A2/integrin beta 3 and downstream signaling molecules. @@@ Conclusion: YSTB inhibits the proliferation and migration of synovial fibroblasts in RA by downregulating the SLC3A2/integrin beta 3 pathways.

学科与关键词

关键词
Collagen-induced arthritisYishen Tongbi decoctionSynovial hyperplasiaSLC3A2Bone destruction
相关
加载中…
  • The Underlying Mechanism of Duanteng Yimu Decoction in Inhibiting Synovial Hyperplasia in Rheumatoid Arthritis
    Feng, Wei; Zhong, Xiao-Qin; Zheng, Xue-Xia; Liu, Qing-Ping; Liu, Min-Ying; Liu, Xiao-Bao; Lin, Chang-Song*; Xu, Qiang*Journal of Immunology Research, 2023, 2023: 2340538.
  • Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial
    Xu, Jia; Zhang, Lu; Xu, Yanping; Yu, Jiahui; Zhao, Lianyu; Deng, Hui; Li, Meiling; Zhang, Mingying; Lei, Xujie; Hu, Congqi; Jiao, Wei; Dai, Zhao; Liu, Lijuan*; Chen, Guangxing*PHYTOMEDICINE, 2023, 112: 154704.被引 3
  • Coptisine inhibits aggressive and proliferative actions of fibroblast like synoviocytes and exerts a therapeutic potential for rheumatoid arthritis
    Xu, Fangqiu; Shen, Chuyu; Zhang, Shuoyang; Liu, Yingli; Liu, Di; Kuang, Yu; Li, Ruiru; Wang, Cuicui; Cai, Xiaoyan*; Shi, Maohua*; Xiao, Youjun*International Immunopharmacology, 2024, 128: 111433.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-06
卷期
第 114 卷
页码
154741
DOI
10.1016/j.phymed.2023.154741
语言
GERMAN
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81573850]; Construction Project of Guangzhou Clinical Core Technology of Chinese Medicine [Guangzhou Health Commission]; Guangzhou Municipal Science and Technology Bureau [202201020555]

作者

  • J

    Jiao, Wei (第一作者)

    1 · guangzhou univ chinese med

  • X

    Xu, Jia

    1 · guangzhou univ chinese med

查看全部 7 位作者收起作者
  • W

    Wu, Danbin

    1 · guangzhou univ chinese med

  • Y

    Yu, Jiahui

    1 · guangzhou univ chinese med

  • Z

    Zhang, Mingying

    1 · guangzhou univ chinese med

  • L

    Liu, Lijuan

    1 · guangzhou univ chinese med

  • C

    Chen, Guangxing (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417